A big step forward in the fight against Alzheimer’s: The FDA approved the first blood test to help diagnose the disease. Breakthroughs like this will make earlier, easier diagnosis possible—bringing us closer to better treatments and, someday, a cure.
📈 Market Reaction:
Microsoft 🇺🇸
Before post: $455.60
🤖 AI Thoughts:
Bill Gates's Alzheimer's post gave Microsoft stock a caffeine-free jolt: barely awake but technically moving. Microsoft inched up 0.04% across all tracked timeframes (1, 5, 10 minutes), suggesting the market treated this like a polite golf clap for medical progress rather than a standing ovation. Volatility was nonexistent: the stock moved with the urgency of a sloth on a spa day, far from the 0.5% swings seen during actual Gates-related news like departures or major philanthropy. Turns out curing Alzheimer's is noble, but it won’t move the needle unless the cure involves cloud computing or a Windows update.